前海开源中药股票C(005506)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
-28,053,872.31 |
-97,034,167.77 |
-83,495,479.96 |
-164,347,332.39 |
| 利息合计 |
214,258.06 |
800,559.04 |
420,730.62 |
858,993.78 |
| 其中:存款利息收入 |
214,258.06 |
800,559.04 |
420,730.62 |
858,993.78 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
-2,792,475.49 |
-234,722,030.08 |
-157,838,387.41 |
-91,036,891.35 |
| 其中:股票投资收益 |
-11,988,425.36 |
-275,653,464.77 |
-185,621,924.45 |
-123,117,116.75 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
- |
- |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
9,195,949.87 |
40,931,434.69 |
27,783,537.04 |
32,080,225.40 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
-25,989,818.16 |
134,213,941.26 |
72,356,992.03 |
-84,928,390.33 |
| 其他收入 |
514,163.28 |
2,673,362.01 |
1,565,184.80 |
10,758,955.51 |
| 费用 |
6,154,255.58 |
20,773,706.44 |
11,485,586.76 |
30,265,476.38 |
| 管理人报酬 |
4,807,338.61 |
16,220,998.76 |
8,969,069.05 |
23,885,567.70 |
| 基金托管费 |
801,223.12 |
2,703,499.81 |
1,494,844.83 |
3,980,928.03 |
| 销售服务费 |
442,474.30 |
1,631,207.87 |
903,274.50 |
2,160,980.65 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
103,219.55 |
218,000.00 |
118,398.38 |
238,000.00 |
| 利润总额 |
-34,208,127.89 |
-117,807,874.21 |
-94,981,066.72 |
-194,612,808.77 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年